TRPM2 and melanoma: The emergence of evidence has revealed that TRPM2, a highly Ca2+ permeable cation channel, acts as a regulator in cancer growth and survival, and is correlated with poor prognosis in patients with breast, gastric, pancreatic, prostate, head and neck cancers, melanoma, and neuroblastoma.